| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.69 | 0.009 | 0.698 | Aldehyde oxidase inhibitor | 0.698 0.008 CID_169703 | CID_169703 | |
| 0.644 | 0.003 | 0.644 | Nav1.1 sodium channel blocker | 0.606 0.003 CID_169703 0.325 0.007 CID_135250 | ||
| 0.564 | 0.005 | 0.564 | Anesthetic general | 0.537 0.006 CID_169703 0.539 0.006 CID_135250 | ||
| 0.544 | 0.009 | 0.544 | Anticonvulsant | 0.495 0.012 CID_169703 | ||
| 0.534 | 0.003 | 0.534 | Aldose reductase inhibitor | 0.527 0.003 CID_169703 0.382 0.004 CID_135250 | ||
| 0.563 | 0.042 | 0.625 | Caspase 9 stimulant | 0.625 0.033 CID_169703 0.529 0.05 CID_135250 | CID_169703 | |
| 0.514 | 0.022 | 0.514 | GABA C receptor rho-3 antagonist | 0.424 0.051 CID_169703 | ||
| 0.453 | 0.014 | 0.462 | Peroxidase inhibitor | 0.462 0.013 CID_169703 | CID_169703 | |
| 0.42 | 0.005 | 0.448 | Tumour necrosis factor antagonist | 0.448 0.005 CID_169703 0.199 0.054 CID_135250 | CID_169703 | |
| 0.364 | 0.004 | 0.364 | Alcohol dehydrogenase inhibitor | 0.339 0.005 CID_169703 0.273 0.006 CID_135250 | ||
| 0.388 | 0.043 | 0.509 | Spasmolytic | 0.412 0.038 CID_169703 0.509 0.022 CID_135250 | CID_135250 | |
| 0.356 | 0.015 | 0.356 | Tyrosine 3 hydroxylase inhibitor | 0.333 0.02 CID_169703 | ||
| 0.363 | 0.022 | 0.379 | RNA-directed DNA polymerase inhibitor | 0.379 0.02 CID_169703 0.285 0.035 CID_135250 | CID_169703 | |
| 0.41 | 0.074 | 0.41 | Calcium channel L-type activator | 0.301 0.157 CID_169703 | ||
| 0.355 | 0.035 | 0.393 | Superoxide dismutase inhibitor | 0.393 0.028 CID_169703 | CID_169703 | |
| 0.385 | 0.099 | 0.802 | Cyclophilin D inhibitor | 0.398 0.092 CID_169703 0.802 0.007 CID_135250 | CID_135250 | |
| 0.35 | 0.064 | 0.597 | Immunostimulant | 0.325 0.072 CID_169703 0.597 0.017 CID_135250 | CID_135250 | |
| 0.394 | 0.118 | 0.433 | DNA directed DNA polymerase inhibitor | 0.433 0.103 CID_169703 | CID_169703 | |
| 0.278 | 0.011 | 0.45 | UDP-glucose 4-epimerase inhibitor | 0.243 0.014 CID_169703 0.45 0.004 CID_135250 | CID_135250 | |
| 0.361 | 0.095 | 0.472 | Histamine release inhibitor | 0.396 0.078 CID_169703 0.472 0.04 CID_135250 | CID_135250 | |
| 0.29 | 0.034 | 0.29 | Growth hormone agonist | 0.237 0.047 CID_169703 | ||
| 0.284 | 0.031 | 0.421 | Peptidyltransferase inhibitor | 0.28 0.033 CID_169703 0.421 0.005 CID_135250 | CID_135250 | |
| 0.29 | 0.047 | 0.451 | DNA synthesis inhibitor | 0.257 0.062 CID_169703 0.451 0.017 CID_135250 | CID_135250 | |
| 0.244 | 0.016 | 0.261 | Cystathionine beta-synthase inhibitor | 0.261 0.014 CID_169703 0.193 0.026 CID_135250 | CID_169703 | |
| 0.271 | 0.054 | 0.42 | Cyclic AMP phosphodiesterase inhibitor | 0.31 0.038 CID_169703 0.42 0.014 CID_135250 | CID_135250 | |
| 0.337 | 0.127 | 0.399 | 5 Hydroxytryptamine release inhibitor | 0.296 0.169 CID_169703 0.399 0.079 CID_135250 | CID_135250 | |
| 0.213 | 0.009 | 0.213 | Phosphodiesterase 7B inhibitor | 0.207 0.009 CID_169703 | ||
| 0.351 | 0.149 | 0.351 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.324 0.182 CID_169703 | ||
| 0.263 | 0.063 | 0.396 | Vasodilator | 0.291 0.051 CID_169703 0.396 0.024 CID_135250 | CID_135250 | |
| 0.251 | 0.056 | 0.251 | Neuropeptide Y2 antagonist | 0.212 0.1 CID_169703 | ||
| 0.236 | 0.043 | 0.249 | Nitric-oxide synthase stimulant | 0.249 0.033 CID_169703 0.232 0.047 CID_135250 | CID_169703 | |
| 0.337 | 0.145 | 0.374 | DNA polymerase beta inhibitor | 0.374 0.129 CID_169703 | CID_169703 | |
| 0.2 | 0.01 | 0.209 | Creatine kinase inhibitor | 0.209 0.009 CID_169703 | CID_169703 | |
| 0.262 | 0.083 | 0.262 | 5 Hydroxytryptamine release stimulant | 0.221 0.105 CID_169703 0.164 0.16 CID_135250 | ||
| 0.203 | 0.033 | 0.295 | M18 aspartyl aminopeptidase inhibitor | 0.295 0.013 CID_169703 | CID_169703 | |
| 0.189 | 0.024 | 0.189 | Nav1.6 sodium channel blocker | 0.168 0.037 CID_169703 | ||
| 0.176 | 0.011 | 0.176 | Keratolytic | 0.168 0.012 CID_169703 | ||
| 0.194 | 0.032 | 0.194 | GABA C receptor rho-2 antagonist | 0.169 0.051 CID_169703 | ||
| 0.197 | 0.036 | 0.197 | Neurotensin receptor agonist | 0.177 0.053 CID_169703 | ||
| 0.244 | 0.087 | 0.283 | 5 Hydroxytryptamine uptake stimulant | 0.283 0.055 CID_169703 | CID_169703 | |
| 0.174 | 0.02 | 0.251 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.15 0.027 CID_169703 0.251 0.01 CID_135250 | CID_135250 | |
| 0.249 | 0.097 | 0.249 | Insulysin inhibitor | 0.239 0.107 CID_169703 | ||
| 0.213 | 0.062 | 0.216 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.216 0.06 CID_169703 0.155 0.137 CID_135250 | CID_169703 | |
| 0.149 | 0.004 | 0.149 | Phosphodiesterase VII inhibitor | 0.148 0.004 CID_169703 | ||
| 0.151 | 0.01 | 0.151 | Alcohol oxidase inhibitor | 0.084 0.023 CID_169703 | ||
| 0.178 | 0.043 | 0.178 | Nav1.2 sodium channel blocker | 0.139 0.064 CID_169703 | ||
| 0.158 | 0.023 | 0.184 | HIV-1 integrase (Overall Integration) inhibitor | 0.184 0.015 CID_169703 | CID_169703 | |
| 0.152 | 0.017 | 0.295 | NADH dehydrogenase inhibitor | 0.15 0.018 CID_169703 0.295 0.007 CID_135250 | CID_135250 | |
| 0.162 | 0.03 | 0.162 | GABA C receptor agonist | 0.142 0.037 CID_169703 | ||
| 0.229 | 0.097 | 0.253 | Cardiotonic | 0.253 0.08 CID_169703 | CID_169703 | |
| 0.284 | 0.154 | 0.284 | Analgesic | |||
| 0.156 | 0.027 | 0.327 | DNA repair enzyme inhibitor | 0.154 0.028 CID_169703 0.327 0.004 CID_135250 | CID_135250 | |
| 0.171 | 0.045 | 0.297 | Alpha-N-acetylglucosaminidase inhibitor | 0.15 0.055 CID_169703 0.297 0.016 CID_135250 | CID_135250 | |
| 0.132 | 0.007 | 0.132 | Cathepsin E inhibitor | 0.123 0.008 CID_169703 0.069 0.03 CID_135250 | ||
| 0.145 | 0.024 | 0.156 | DOPA decarboxylase inhibitor | 0.156 0.018 CID_169703 | CID_169703 | |
| 0.135 | 0.014 | 0.135 | Phenylalanine 4-hydroxylase inhibitor | 0.132 0.015 CID_169703 | ||
| 0.184 | 0.064 | 0.205 | Succinate dehydrogenase inhibitor | 0.205 0.045 CID_169703 | CID_169703 | |
| 0.214 | 0.1 | 0.641 | Hypoglycemic | 0.221 0.095 CID_169703 0.641 0.006 CID_135250 | CID_135250 | |
| 0.283 | 0.169 | 0.538 | Alpha-glucosidase inhibitor | 0.307 0.156 CID_169703 0.538 0.07 CID_135250 | CID_135250 | |
| 0.131 | 0.021 | 0.131 | Metalloproteinase-9 inhibitor | 0.126 0.023 CID_169703 | ||
| 0.134 | 0.024 | 0.134 | Metalloproteinase-2 inhibitor | 0.127 0.026 CID_169703 | ||
| 0.164 | 0.055 | 0.164 | CF transmembrane conductance regulator agonist | 0.128 0.122 CID_169703 | ||
| 0.112 | 0.004 | 0.112 | Phosphodiesterase 7A inhibitor | 0.11 0.004 CID_169703 | ||
| 0.129 | 0.023 | 0.129 | Histidine decarboxylase inhibitor | 0.126 0.024 CID_169703 | ||
| 0.156 | 0.053 | 0.166 | Adenylate cyclase stimulant | 0.166 0.039 CID_169703 | CID_169703 | |
| 0.119 | 0.016 | 0.138 | Phosphodiesterase III inhibitor | 0.138 0.012 CID_169703 | CID_169703 | |
| 0.189 | 0.088 | 0.203 | Neurotrophic factor enhancer | 0.203 0.074 CID_169703 0.194 0.083 CID_135250 | CID_169703 | |
| 0.11 | 0.01 | 0.11 | Phospholipase D inhibitor | 0.097 0.017 CID_169703 | ||
| 0.198 | 0.099 | 0.503 | Free radical scavenger | 0.289 0.055 CID_169703 0.503 0.016 CID_135250 | CID_135250 | |
| 0.157 | 0.059 | 0.185 | Mannose-6-phosphate isomerase inhibitor | 0.185 0.039 CID_169703 0.167 0.051 CID_135250 | CID_169703 | |
| 0.099 | 0.004 | 0.099 | Calcitonin gene-related peptide 1 receptor antagonist | 0.077 0.004 CID_169703 | ||
| 0.135 | 0.04 | 0.211 | Xanthine oxidase inhibitor | 0.15 0.034 CID_169703 0.211 0.017 CID_135250 | CID_135250 | |
| 0.137 | 0.043 | 0.137 | 5 Hydroxytryptamine 3A agonist | 0.113 0.062 CID_169703 | ||
| 0.144 | 0.052 | 0.144 | Nav1.3 sodium channel blocker | 0.117 0.077 CID_169703 | ||
| 0.146 | 0.054 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.141 0.068 CID_169703 0.141 0.07 CID_135250 | ||
| 0.117 | 0.026 | 0.117 | Interleukin 5 antagonist | 0.096 0.046 CID_169703 0.107 0.034 CID_135250 | ||
| 0.113 | 0.023 | 0.113 | Glutamate decarboxylase inhibitor | 0.104 0.027 CID_169703 | ||
| 0.094 | 0.006 | 0.094 | Dihydroorotate oxidase inhibitor | 0.092 0.006 CID_169703 | ||
| 0.122 | 0.038 | 0.122 | Anabolic | 0.118 0.041 CID_169703 | ||
| 0.101 | 0.018 | 0.101 | Biliverdin reductase inhibitor | 0.087 0.023 CID_169703 0.064 0.036 CID_135250 | ||
| 0.105 | 0.024 | 0.109 | D-Ala-D-Ala ligase inhibitor | 0.109 0.02 CID_169703 | CID_169703 | |
| 0.095 | 0.017 | 0.095 | Carbonic anhydrase VB inhibitor | 0.089 0.019 CID_169703 | ||
| 0.095 | 0.018 | 0.095 | NMDA 2C receptor antagonist | 0.073 0.03 CID_169703 | ||
| 0.107 | 0.033 | 0.107 | Porphobilinogen synthase inhibitor | 0.088 0.042 CID_169703 | ||
| 0.116 | 0.041 | 0.116 | Prolactin inhibitor | 0.111 0.045 CID_169703 | ||
| 0.078 | 0.004 | 0.078 | Calcitonin gene-related peptide antagonist | 0.074 0.004 CID_169703 0.033 0.014 CID_135250 | ||
| 0.194 | 0.12 | 0.224 | DNA damaging | 0.224 0.097 CID_169703 0.22 0.101 CID_135250 | CID_169703 | |
| 0.237 | 0.163 | 0.237 | Calcium channel activator | |||
| 0.22 | 0.147 | 0.464 | Cholesterol antagonist | 0.216 0.151 CID_169703 0.464 0.038 CID_135250 | CID_135250 | |
| 0.102 | 0.031 | 0.198 | Phosphofructokinase-1 inhibitor | 0.089 0.036 CID_169703 0.198 0.011 CID_135250 | CID_135250 | |
| 0.098 | 0.027 | 0.098 | Estrogen-related receptor beta agonist | 0.088 0.046 CID_169703 | ||
| 0.097 | 0.026 | 0.097 | CC chemokine 5 receptor agonist | 0.089 0.039 CID_169703 | ||
| 0.115 | 0.045 | 0.115 | GABA C receptor rho-1 antagonist | 0.095 0.069 CID_169703 | ||
| 0.107 | 0.037 | 0.107 | Phosphodiesterase I inhibitor | 0.107 0.037 CID_169703 | ||
| 0.11 | 0.041 | 0.11 | NMDA receptor antagonist | 0.082 0.063 CID_169703 | ||
| 0.09 | 0.022 | 0.09 | NMDA receptor glycine site agonist | 0.083 0.026 CID_169703 | ||
| 0.121 | 0.053 | 0.121 | Ferrochelatase inhibitor | 0.103 0.068 CID_169703 | ||
| 0.095 | 0.027 | 0.095 | Carbonic anhydrase VA inhibitor | 0.09 0.03 CID_169703 | ||
| 0.119 | 0.054 | 0.119 | GABA C receptor antagonist | 0.098 0.082 CID_169703 | ||
| 0.083 | 0.019 | 0.098 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.074 0.023 CID_169703 0.098 0.015 CID_135250 | CID_135250 | |
| 0.082 | 0.019 | 0.082 | NMDA 2A receptor antagonist | 0.057 0.031 CID_169703 | ||
| 0.093 | 0.029 | 0.093 | Carbonic anhydrase V inhibitor | 0.087 0.032 CID_169703 | ||
| 0.071 | 0.008 | 0.071 | Nicotinic acid receptor agonist | 0.045 0.017 CID_169703 | ||
| 0.085 | 0.022 | 0.085 | Collagenase 3 inhibitor | 0.075 0.028 CID_169703 | ||
| 0.089 | 0.026 | 0.089 | Secretase beta inhibitor | 0.087 0.028 CID_169703 | ||
| 0.084 | 0.023 | 0.084 | Glutamate (mGluR7) antagonist | 0.077 0.032 CID_169703 | ||
| 0.109 | 0.048 | 0.109 | Estrogen receptor beta antagonist | |||
| 0.088 | 0.027 | 0.088 | Neutrophil collagenase inhibitor | 0.086 0.028 CID_169703 | ||
| 0.066 | 0.005 | 0.079 | Uridine phosphorylase inhibitor | 0.059 0.005 CID_169703 0.079 0.004 CID_135250 | CID_135250 | |
| 0.154 | 0.094 | 0.277 | ATPase inhibitor | 0.154 0.095 CID_169703 0.277 0.009 CID_135250 | CID_135250 | |
| 0.091 | 0.031 | 0.091 | Matrix metalloproteinase inhibitor | 0.085 0.034 CID_169703 | ||
| 0.099 | 0.039 | 0.102 | Carbonic anhydrase VI inhibitor | 0.102 0.038 CID_169703 | CID_169703 | |
| 0.098 | 0.038 | 0.098 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.092 0.042 CID_169703 | ||
| 0.124 | 0.064 | 0.143 | Adenylate cyclase inhibitor | 0.143 0.05 CID_169703 | CID_169703 | |
| 0.068 | 0.009 | 0.079 | Dopamine D5 agonist | 0.079 0.006 CID_169703 | CID_169703 | |
| 0.185 | 0.127 | 0.547 | Antioxidant | 0.255 0.081 CID_169703 0.547 0.015 CID_135250 | CID_135250 | |
| 0.093 | 0.035 | 0.093 | Analgesic, opioid | 0.071 0.059 CID_169703 | ||
| 0.138 | 0.081 | 0.142 | Heat shock protein 70 antagonist | 0.139 0.079 CID_169703 0.142 0.067 CID_135250 | CID_135250 | |
| 0.084 | 0.027 | 0.084 | Carbamoyl phosphate synthetase inhibitor | 0.074 0.032 CID_169703 | ||
| 0.106 | 0.05 | 0.106 | DNA directed RNA polymerase inhibitor | 0.104 0.052 CID_169703 | ||
| 0.06 | 0.005 | 0.062 | Protein kinase (CK2) beta inhibitor | 0.062 0.005 CID_169703 | CID_169703 | |
| 0.077 | 0.022 | 0.078 | Phosphodiesterase 1C inhibitor | 0.078 0.021 CID_169703 | CID_169703 | |
| 0.173 | 0.119 | 0.221 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.221 0.089 CID_169703 | CID_169703 | |
| 0.08 | 0.029 | 0.08 | NMDA receptor agonist | 0.066 0.039 CID_169703 | ||
| 0.115 | 0.065 | 0.115 | Estrogen antagonist | |||
| 0.098 | 0.05 | 0.186 | Triose-phosphate isomerase inhibitor | 0.089 0.061 CID_169703 0.186 0.013 CID_135250 | CID_135250 | |
| 0.199 | 0.151 | 0.199 | Gastrin inhibitor | |||
| 0.068 | 0.021 | 0.072 | Ryanodine receptor antagonist | 0.072 0.015 CID_169703 | CID_169703 | |
| 0.074 | 0.028 | 0.074 | Argininosuccinate synthase inhibitor | 0.064 0.034 CID_169703 | ||
| 0.107 | 0.06 | 0.255 | Beta glucuronidase inhibitor | 0.11 0.056 CID_169703 0.255 0.008 CID_135250 | CID_135250 | |
| 0.084 | 0.037 | 0.084 | MAP kinase kinase 7 inhibitor | 0.078 0.052 CID_169703 | ||
| 0.116 | 0.072 | 0.227 | Alkylator | 0.117 0.071 CID_169703 0.227 0.02 CID_135250 | CID_135250 | |
| 0.111 | 0.068 | 0.256 | Monophenol monooxygenase inhibitor | 0.114 0.066 CID_169703 0.256 0.023 CID_135250 | CID_135250 | |
| 0.141 | 0.099 | 0.165 | Arachidonic acid antagonist | 0.165 0.071 CID_169703 | CID_169703 | |
| 0.134 | 0.092 | 0.304 | Insulin secretagoues | 0.136 0.09 CID_169703 0.304 0.012 CID_135250 | CID_135250 | |
| 0.108 | 0.067 | 0.115 | Mucolytic | 0.115 0.059 CID_169703 0.114 0.06 CID_135250 | CID_169703 | |
| 0.07 | 0.03 | 0.07 | Phosphodiesterase 1B inhibitor | 0.068 0.033 CID_169703 | ||
| 0.07 | 0.031 | 0.07 | Androgen agonist | 0.064 0.036 CID_169703 | ||
| 0.102 | 0.064 | 0.102 | Adenylate kinase inhibitor | 0.094 0.078 CID_169703 | ||
| 0.067 | 0.028 | 0.067 | Phosphodiesterase 1A inhibitor | 0.065 0.031 CID_169703 | ||
| 0.051 | 0.013 | 0.051 | Kainate receptor agonist | 0.047 0.017 CID_169703 | ||
| 0.148 | 0.11 | 0.148 | Phospholipase C inhibitor | 0.143 0.12 CID_169703 | ||
| 0.135 | 0.097 | 0.135 | Cyclin-dependent kinase 8 inhibitor | 0.131 0.101 CID_169703 | ||
| 0.041 | 0.005 | 0.041 | Nicotinic acid receptor 2 antagonist | 0.036 0.007 CID_169703 | ||
| 0.091 | 0.054 | 0.091 | Bromodomain-containing protein 2 inhibitor | 0.09 0.055 CID_169703 | ||
| 0.052 | 0.018 | 0.052 | Thymidine kinase inhibitor | 0.048 0.02 CID_169703 | ||
| 0.136 | 0.103 | 0.197 | Melanin inhibitor | 0.139 0.097 CID_169703 0.197 0.042 CID_135250 | CID_135250 | |
| 0.079 | 0.045 | 0.079 | GABA B receptor agonist | 0.075 0.053 CID_169703 | ||
| 0.133 | 0.1 | 0.249 | Hexokinase inhibitor | 0.249 0.017 CID_135250 | CID_135250 | |
| 0.048 | 0.015 | 0.048 | Nicotinic acid receptor 2 agonist | 0.037 0.024 CID_169703 | ||
| 0.081 | 0.049 | 0.088 | Carbonic anhydrase XIII inhibitor | 0.088 0.044 CID_169703 0.083 0.048 CID_135250 | CID_169703 | |
| 0.084 | 0.053 | 0.084 | Adrenaline agonist | 0.081 0.057 CID_169703 | ||
| 0.07 | 0.039 | 0.07 | MDM2 inhibitor | 0.067 0.047 CID_169703 | ||
| 0.077 | 0.046 | 0.078 | Lipase inhibitor | 0.078 0.045 CID_169703 | CID_169703 | |
| 0.088 | 0.058 | 0.088 | Opioid antagonist | |||
| 0.087 | 0.058 | 0.104 | Granulocyte macrophage colony stimulating factor agonist | 0.104 0.03 CID_169703 | CID_169703 | |
| 0.055 | 0.027 | 0.055 | Bombesin 2 receptor antagonist | 0.047 0.039 CID_169703 | ||
| 0.072 | 0.044 | 0.072 | Opioid mu receptor antagonist | |||
| 0.075 | 0.047 | 0.075 | NMDA 2 receptor antagonist | |||
| 0.19 | 0.163 | 0.211 | 12-Lipoxygenase inhibitor | 0.211 0.139 CID_169703 | CID_169703 | |
| 0.035 | 0.009 | 0.036 | Thyroid hormone agonist | 0.036 0.008 CID_169703 | CID_169703 | |
| 0.034 | 0.009 | 0.034 | Thymidine phosphorylase inhibitor | 0.033 0.009 CID_169703 | ||
| 0.093 | 0.067 | 0.134 | Phosphodiesterase 6D inhibitor | 0.096 0.06 CID_169703 0.134 0.015 CID_135250 | CID_135250 | |
| 0.199 | 0.174 | 0.212 | Thioredoxin glutathione reductase inhibitor | 0.212 0.162 CID_169703 | CID_169703 | |
| 0.073 | 0.049 | 0.073 | Glycine receptor agonist | 0.066 0.063 CID_169703 | ||
| 0.125 | 0.101 | 0.125 | Acetylcholine M1 receptor antagonist | 0.116 0.114 CID_169703 | ||
| 0.063 | 0.039 | 0.063 | Beta 2 adrenoreceptor agonist | 0.061 0.044 CID_169703 | ||
| 0.068 | 0.045 | 0.068 | Glutamate (mGluR6) antagonist | 0.063 0.057 CID_169703 | ||
| 0.11 | 0.088 | 0.346 | Amylase inhibitor | 0.12 0.081 CID_169703 0.346 0.013 CID_135250 | CID_135250 | |
| 0.094 | 0.071 | 0.104 | Bronchodilator | 0.104 0.059 CID_169703 | CID_169703 | |
| 0.092 | 0.071 | 0.092 | Aminopeptidase B inhibitor | |||
| 0.125 | 0.105 | 0.284 | NOS3 expression enhancer | 0.139 0.085 CID_169703 0.284 0.02 CID_135250 | CID_135250 | |
| 0.079 | 0.059 | 0.127 | Glycine receptor antagonist | 0.078 0.061 CID_169703 0.127 0.015 CID_135250 | CID_135250 | |
| 0.115 | 0.095 | 0.115 | Papain-like protease (SARS coronavirus) inhibitor | 0.112 0.106 CID_169703 | ||
| 0.056 | 0.037 | 0.056 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.039 CID_169703 | ||
| 0.023 | 0.005 | 0.024 | Thyroid hormone alpha agonist | 0.024 0.005 CID_169703 | CID_169703 | |
| 0.072 | 0.054 | 0.072 | Glutamate dehydrogenase inhibitor | |||
| 0.045 | 0.029 | 0.045 | NMDA receptor subunit 3B antagonist | |||
| 0.048 | 0.031 | 0.157 | Phosphorylase inhibitor | 0.039 0.038 CID_169703 0.157 0.007 CID_135250 | CID_135250 | |
| 0.067 | 0.052 | 0.073 | Alpha 1a adrenoreceptor antagonist | 0.073 0.049 CID_169703 | CID_169703 | |
| 0.103 | 0.089 | 0.108 | Interleukin 8 antagonist | 0.108 0.08 CID_169703 | CID_169703 | |
| 0.046 | 0.033 | 0.046 | Thymidylate synthase inhibitor | |||
| 0.028 | 0.014 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.016 CID_169703 | ||
| 0.089 | 0.076 | 0.089 | Electrolyte absorption antagonist | |||
| 0.056 | 0.042 | 0.056 | Pregnane X receptor antagonist | 0.053 0.05 CID_169703 | ||
| 0.023 | 0.01 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.011 CID_169703 | ||
| 0.113 | 0.101 | 0.255 | Lipid peroxidase inhibitor | 0.154 0.066 CID_169703 0.255 0.026 CID_135250 | CID_135250 | |
| 0.042 | 0.03 | 0.042 | Oxytocin agonist | |||
| 0.087 | 0.075 | 0.097 | Protein kinase (CK2) inhibitor | 0.097 0.066 CID_169703 | CID_169703 | |
| 0.024 | 0.012 | 0.024 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.054 | 0.043 | 0.064 | Xanthine dehydrogenase inhibitor | 0.064 0.036 CID_169703 | CID_169703 | |
| 0.054 | 0.044 | 0.057 | Fatty acid synthase inhibitor | 0.057 0.04 CID_169703 | CID_169703 | |
| 0.054 | 0.044 | 0.07 | Adenine nucleotide translocase inhibitor | 0.059 0.031 CID_169703 0.07 0.015 CID_135250 | CID_135250 | |
| 0.164 | 0.154 | 0.301 | Interleukin agonist | 0.18 0.139 CID_169703 0.301 0.047 CID_135250 | CID_135250 | |
| 0.033 | 0.024 | 0.033 | Purinergic P2Y2 antagonist | |||
| 0.012 | 0.003 | 0.012 | DNA topoisomerase III inhibitor | 0.01 0.004 CID_169703 | ||
| 0.039 | 0.03 | 0.039 | CF transmembrane conductance regulator antagonist | |||
| 0.091 | 0.083 | 0.291 | AMP-activated protein kinase stimulant | 0.092 0.082 CID_169703 0.291 0.005 CID_135250 | CID_135250 | |
| 0.043 | 0.036 | 0.043 | Opioid mu receptor agonist | |||
| 0.038 | 0.031 | 0.038 | Nicotinic acid receptor 1 agonist | |||
| 0.061 | 0.053 | 0.061 | Beta 3 adrenoreceptor antagonist | 0.061 0.053 CID_169703 | ||
| 0.014 | 0.006 | 0.014 | Egl nine homolog 3 inhibitor | 0.011 0.009 CID_169703 | ||
| 0.044 | 0.037 | 0.044 | Beta adrenoreceptor agonist | 0.043 0.041 CID_169703 | ||
| 0.032 | 0.026 | 0.032 | Fumarate hydratase inhibitor | |||
| 0.068 | 0.064 | 0.068 | GABA aminotransferase inhibitor | |||
| 0.122 | 0.119 | 0.126 | Sphingosine 1-phosphate receptor 5 antagonist | 0.126 0.11 CID_169703 | CID_169703 | |
| 0.023 | 0.021 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.041 | 0.039 | 0.042 | Carbonic anhydrase VII inhibitor | 0.042 0.037 CID_169703 | CID_169703 | |
| 0.024 | 0.023 | 0.024 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.087 | 0.086 | 0.273 | Expectorant | 0.096 0.074 CID_169703 0.273 0.01 CID_135250 | CID_135250 | |
| 0.046 | 0.045 | 0.046 | Opioid agonist | |||
| 0.084 | 0.084 | 0.086 | Carbonic anhydrase III inhibitor | 0.086 0.081 CID_169703 | CID_169703 | |
| 0.008 | 0.008 | 0.008 | Thyroid hormone beta agonist | 0.008 0.006 CID_169703 | CID_169703 | |
| 0.101 | 0.103 | 0.116 | Toll-Like receptor 2 antagonist | 0.116 0.082 CID_169703 | CID_169703 | |
| 0.124 | 0.125 | 0.212 | Interferon gamma antagonist | 0.129 0.112 CID_169703 0.212 0.037 CID_135250 | CID_135250 | |
| 0.145 | 0.148 | 0.152 | Histone acetyltransferase inhibitor | 0.152 0.137 CID_169703 | CID_169703 | |
| 0.212 | 0.216 | 0.61 | Antibacterial | 0.217 0.21 CID_169703 0.61 0.018 CID_135250 | CID_135250 | |
| 0.008 | 0.012 | 0.013 | Purinergic P2Y2 agonist | 0.013 0.005 CID_135250 | CID_135250 | |
| 0.188 | 0.193 | 0.368 | Vasodilator, coronary | 0.199 0.183 CID_169703 0.368 0.047 CID_135250 | CID_135250 | |
| 0.041 | 0.049 | 0.06 | Glucose-6-phosphate isomerase inhibitor | 0.06 0.019 CID_135250 | CID_135250 | |
| 0.06 | 0.068 | 0.068 | Alpha 1 adrenoreceptor antagonist | 0.068 0.061 CID_169703 | CID_169703 | |
| 0.018 | 0.028 | 0.029 | Dopamine D1 agonist | 0.029 0.009 CID_169703 0.026 0.012 CID_135250 | CID_169703 | |
| 0.088 | 0.099 | 0.218 | Topoisomerase II inhibitor | 0.1 0.086 CID_169703 0.218 0.029 CID_135250 | CID_135250 | |
| 0.178 | 0.192 | 0.472 | Transcription factor NF kappa B inhibitor | 0.199 0.17 CID_169703 0.472 0.049 CID_135250 | CID_135250 | |
| 0.035 | 0.05 | 0.046 | Dihydroorotase inhibitor | 0.046 0.029 CID_169703 | CID_169703 | |
| 0.053 | 0.068 | 0.069 | HIV-1 reverse transcriptase inhibitor | 0.069 0.05 CID_169703 | CID_169703 | |
| 0.191 | 0.206 | 0.406 | Interleukin 2 agonist | 0.406 0.026 CID_135250 | CID_135250 | |
| 0.182 | 0.199 | 0.256 | Caspase 3 stimulant | 0.226 0.136 CID_169703 0.256 0.107 CID_135250 | CID_135250 | |
| 0.1 | 0.121 | 0.205 | Protein kinase stimulant | 0.205 0.04 CID_135250 | CID_135250 | |
| 0.085 | 0.105 | 0.133 | DNA polymerase I inhibitor | 0.122 0.067 CID_169703 0.133 0.059 CID_135250 | CID_135250 | |
| 0.104 | 0.127 | 0.259 | Cell wall synthesis inhibitor | 0.259 0.014 CID_135250 | CID_135250 | |
| 0.064 | 0.09 | 0.076 | Alpha adrenoreceptor antagonist | 0.076 0.075 CID_169703 | CID_169703 | |
| 0.013 | 0.044 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_135250 | CID_135250 | |
| 0.038 | 0.076 | 0.084 | Alpha-mannosidase inhibitor | 0.084 0.01 CID_135250 | CID_135250 | |
| 0.043 | 0.082 | 0.072 | HIV-1 integrase (3'-Processing) inhibitor | 0.072 0.038 CID_169703 | CID_169703 | |
| 0.039 | 0.081 | 0.125 | Heparanase inhibitor | 0.125 0.003 CID_135250 | CID_135250 | |
| 0.017 | 0.061 | 0.068 | Sodium/glucose cotransporter inhibitor | 0.068 0.004 CID_135250 | CID_135250 | |
| 0.091 | 0.136 | 0.108 | Interleukin 4 antagonist | 0.107 0.105 CID_169703 0.108 0.105 CID_135250 | CID_135250 | |
| 0.069 | 0.115 | 0.115 | Thioredoxin inhibitor | 0.115 0.034 CID_135250 | CID_135250 | |
| 0.027 | 0.074 | 0.083 | Mannosidase inhibitor | 0.083 0.008 CID_135250 | CID_135250 | |
| 0.082 | 0.132 | 0.12 | Photosensitizer | 0.12 0.057 CID_135250 | CID_135250 | |
| 0.11 | 0.161 | 0.195 | DNA methyltransferase I inhibitor | 0.135 0.122 CID_169703 0.195 0.072 CID_135250 | CID_135250 | |
| 0.051 | 0.103 | 0.068 | HIV-1 integrase inhibitor | 0.068 0.052 CID_169703 | CID_169703 | |
| 0.037 | 0.091 | 0.062 | Dopamine agonist | 0.062 0.05 CID_169703 | CID_169703 | |
| 0.117 | 0.174 | 0.142 | Lipocortins synthesis antagonist | 0.142 0.117 CID_169703 | CID_169703 | |
| 0.032 | 0.093 | 0.053 | HIV-1 integrase (Strand Transfer) inhibitor | 0.053 0.047 CID_169703 | CID_169703 | |
| 0.01 | 0.073 | 0.037 | Arginase inhibitor | 0.037 0.025 CID_135250 | CID_135250 | |
| 0.014 | 0.083 | 0.024 | Vanilloid 2 agonist | 0.024 0.022 CID_135250 | CID_135250 | |
| 0.062 | 0.132 | 0.122 | ATPase (Vacuolar H+) inhibitor | 0.083 0.071 CID_169703 0.122 0.018 CID_135250 | CID_135250 | |
| 0.155 | 0.243 | 0.568 | Antithrombotic | 0.568 0.02 CID_135250 | CID_135250 | |
| 0.037 | 0.126 | 0.078 | Na+ K+ transporting ATPase inhibitor | 0.078 0.052 CID_135250 | CID_135250 | |
| 0.117 | 0.209 | 0.138 | Death-associated protein kinase 2 inhibitor | 0.138 0.136 CID_169703 | CID_169703 | |
| 0.1 | 0.193 | 0.21 | DNA methylase inhibitor | 0.21 0.073 CID_135250 | CID_135250 | |
| 0.013 | 0.108 | 0.032 | Catechol O-methyltransferase inhibitor | 0.032 0.023 CID_169703 | CID_169703 | |
| 0.009 | 0.119 | 0.05 | Sodium/glucose cotransporter 2 inhibitor | 0.05 0.006 CID_135250 | CID_135250 | |
| 0.056 | 0.174 | 0.138 | Transcription factor NF kappa B stimulant | 0.138 0.019 CID_135250 | CID_135250 | |
| 0.035 | 0.156 | 0.107 | Topoisomerase II alpha inhibitor | 0.107 0.035 CID_135250 | CID_135250 | |
| 0.066 | 0.188 | 0.204 | Cyclooxygenase 3 inhibitor | 0.204 0.017 CID_135250 | CID_135250 | |
| 0.039 | 0.177 | 0.18 | Topoisomerase I inhibitor | 0.18 0.032 CID_135250 | CID_135250 | |
| 0.085 | 0.228 | 0.391 | Hepatoprotectant | 0.391 0.014 CID_135250 | CID_135250 | |
| 0.069 | 0.235 | 0.157 | Diuretic | 0.157 0.072 CID_135250 | CID_135250 | |
| 0.019 | 0.185 | 0.161 | Antineoplastic antibiotic | 0.161 0.029 CID_135250 | CID_135250 | |
| 0.062 | 0.233 | 0.644 | Angiogenesis stimulant | 0.644 0.005 CID_135250 | CID_135250 | |
| 0.039 | 0.213 | 0.105 | Mediator release inhibitor | 0.105 0.065 CID_135250 | CID_135250 | |
| 0.057 | 0.233 | 0.095 | Interleukin 12 antagonist | 0.095 0.063 CID_135250 | CID_135250 | |
| 0.009 | 0.196 | 0.045 | Protein 30S ribosomal subunit inhibitor | 0.045 0.009 CID_135250 | CID_135250 | |
| 0.076 | 0.274 | 0.187 | Interleukin 6 antagonist | 0.187 0.049 CID_135250 | CID_135250 | |
| 0.016 | 0.219 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.028 CID_135250 | CID_135250 | |
| 0.071 | 0.276 | 0.316 | Nitric oxide antagonist | 0.316 0.037 CID_135250 | CID_135250 | |
| 0.037 | 0.263 | 0.088 | Uric acid excretion stimulant | 0.088 0.068 CID_135250 | CID_135250 | |
| 0.035 | 0.262 | 0.06 | Lipocortins synthesis agonist | 0.06 0.035 CID_135250 | CID_135250 | |
| 0.069 | 0.308 | 0.268 | Hemostatic | 0.268 0.019 CID_135250 | CID_135250 | |
| 0.016 | 0.261 | 0.072 | Antibiotic Aminoglycoside-like | 0.072 0.006 CID_135250 | CID_135250 | |
| 0.103 | 0.35 | 0.436 | Immunomodulator | 0.436 0.034 CID_135250 | CID_135250 | |
| 0.094 | 0.353 | 0.138 | CC chemokine 6 receptor antagonist | 0.138 0.046 CID_135250 | CID_135250 | |
| 0.014 | 0.273 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 CID_135250 | CID_135250 | |
| 0.029 | 0.295 | 0.095 | DNA intercalator | 0.095 0.079 CID_135250 | CID_135250 | |
| 0.059 | 0.331 | 0.283 | Platelet antagonist | 0.283 0.059 CID_135250 | CID_135250 | |
| 0.016 | 0.3 | 0.065 | Neuraminidase (influenza) inhibitor | 0.065 0.042 CID_135250 | CID_135250 | |
| 0.115 | 0.432 | 0.465 | Apoptosis agonist | 0.465 0.086 CID_135250 | CID_135250 | |
| 0.016 | 0.339 | 0.056 | Nitric oxide donor | 0.056 0.055 CID_135250 | CID_135250 | |
| 0.056 | 0.387 | 0.149 | Non-steroidal antiinflammatory agent | 0.149 0.115 CID_135250 | CID_135250 | |
| 0.01 | 0.357 | 0.336 | Selectin antagonist | 0.336 0.004 CID_135250 | CID_135250 | |
| 0.091 | 0.457 | 0.358 | Apoptosis antagonist | 0.358 0.052 CID_135250 | CID_135250 | |
| 0.017 | 0.384 | 0.069 | Glucose-6-phosphate translocase inhibitor | 0.069 0.017 CID_135250 | CID_135250 | |
| 0.062 | 0.43 | 0.447 | Immunosuppressant | 0.447 0.048 CID_135250 | CID_135250 | |
| 0.033 | 0.412 | 0.141 | Toll-Like receptor 4 antagonist | 0.141 0.026 CID_135250 | CID_135250 | |
| 0.023 | 0.407 | 0.114 | Cell adhesion molecule inhibitor | 0.114 0.026 CID_135250 | CID_135250 | |
| 0.032 | 0.461 | 0.212 | Cell adhesion inhibitor | 0.212 0.022 CID_135250 | CID_135250 | |
| 0.096 | 0.539 | 0.686 | Antiinflammatory | 0.686 0.034 CID_135250 | CID_135250 | |
| 0.035 | 0.512 | 0.333 | Tumour necrosis factor alpha release inhibitor | 0.333 0.043 CID_135250 | CID_135250 | |
| 0.009 | 0.537 | 0.09 | Protein 50S ribosomal subunit inhibitor | 0.09 0.016 CID_135250 | CID_135250 | |
| 0.015 | 0.558 | 0.066 | Factor IXa inhibitor | 0.066 0.023 CID_135250 | CID_135250 | |
| 0.012 | 0.691 | 0.226 | Thrombolytic | 0.226 0.041 CID_135250 | CID_135250 | |
| 0.011 | 0.696 | 0.16 | Hypolipemic | 0.16 0.127 CID_135250 | CID_135250 | |
| 0.009 | 0.72 | 0.164 | Anticoagulant | 0.164 0.07 CID_135250 | CID_135250 | |
| 0.017 | 0.76 | 0.294 | Platelet adhesion inhibitor | 0.294 0.036 CID_135250 | CID_135250 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |